To Identify Suspect in Idaho Killings, F.B.I. Used Restricted Consumer DNA Data
By Mike Baker,
The New York Times
| 02. 25. 2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that was found at the scene of the crime.
At first they tried checking the DNA with law enforcement databases, but that did not provide a hit. They turned next to the more expansive DNA profiles available in some consumer databases in which users had consented to law enforcement possibly using their information, but that also did not lead to answers.
F.B.I. investigators then went a step further, according to newly released testimony, comparing the DNA profile from the knife sheath with two databases that law enforcement officials are not supposed to tap: GEDmatch and MyHeritage.
It was a decision that appears to have violated key parameters of a Justice Department policy that calls for investigators to operate only in DNA databases “that provide explicit notice to their service users and the public that law enforcement may use their service sites.”...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...